Literature DB >> 7774003

The protective effect of portoarterial shunts after experimental hepatic artery embolization in rats with liver cirrhosis.

H Demachi1, O Matsui, Y Kawamori, K Ueda, T Takashima.   

Abstract

PURPOSE: The role of the portal system after hepatic artery embolization (HAE) was examined.
METHODS: Using a Wistar strain rat model of liver cirrhosis, the route and occurrence of portoarterial (PA) shunts before and after HAE by scanning electron microscopic (SEM) and histologic methods were evaluated. HAE was performed with iodized oil and gelatin sponge particles.
RESULTS: In the SEM study, PA shunts did not develop in normal rats regardless of whether they did (n = 10) or did not have HAE (n = 5). The cirrhotic rat model showed PA shunts in both HAE (n = 5) and non-HAE (n = 5) animals. PA shunts were established via the peribiliary plexus and direct arterioportal anastomosis. In the histologic study, the occurrence of PA shunts in liver cirrhosis was significantly increased by HAE (HAE = 6, non-HAE = 6, p < 0.01).
CONCLUSION: The development of PA shunts, which help perfuse liver parenchyma, may explain why HAE can be safely performed in patients with liver cirrhosis.

Entities:  

Mesh:

Year:  1995        PMID: 7774003     DOI: 10.1007/bf02807230

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  19 in total

1.  Primary and metastatic carcinoma of the liver. Relationship to hepatic cirrhosis.

Authors:  E A GALL
Journal:  Arch Pathol       Date:  1960-08

2.  Scanning electron microscopy of intrahepatic microvasculature casts following experimental hepatic artery embolization.

Authors:  H Demachi; O Matsui; T Takashima
Journal:  Cardiovasc Intervent Radiol       Date:  1991 May-Jun       Impact factor: 2.740

3.  An improved plastic mixture for corrosion casting of the gastrointestinal microvascular system.

Authors:  W Nopanitaya; J G Aghajanian; L D Gray
Journal:  Scan Electron Microsc       Date:  1979

4.  Peripheral hepatic artery embolization for primary and secondary hepatic neoplasms.

Authors:  M E Clouse; R G Lee; E J Duszlak; J J Lokich; C Trey; M R Alday; D C Yoburn; J Diamond; A W Crosson; P Costello
Journal:  Radiology       Date:  1983-05       Impact factor: 11.105

5.  Development of collateral circulation following distal embolization of hepatic artery in pigs.

Authors:  H Stridbeck; L E Lorelius; T E Pirtle
Journal:  Cardiovasc Intervent Radiol       Date:  1984       Impact factor: 2.740

6.  Hepatic artery embolization in 120 patients with unresectable hepatoma.

Authors:  R Yamada; M Sato; M Kawabata; H Nakatsuka; K Nakamura; S Takashima
Journal:  Radiology       Date:  1983-08       Impact factor: 11.105

7.  A dynamic and static study of hepatic arterioles and hepatic sphincters.

Authors:  R S McCuskey
Journal:  Am J Anat       Date:  1966-11

8.  Transcatheter oily chemoembolization of hepatocellular carcinoma.

Authors:  H Nakamura; T Hashimoto; H Oi; S Sawada
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

9.  [Intrahepatic microvascular changes after intrahepatic arterial injection of lipiodol in normal and cirrhotic rats].

Authors:  A Ohkusa
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1992-06-25

10.  Occurrence of an intrahepatic porto-arterial shunt after hepatic artery embolization with Gelfoam powder in rats and rabbits.

Authors:  O Matsui; I Kawamura; T Takashima
Journal:  Acta Radiol Diagn (Stockh)       Date:  1986 Jan-Feb
View more
  2 in total

1.  Intrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management.

Authors:  Bo Zhang; Yongjian Guo; Ketong Wu; Hong Shan
Journal:  Mol Clin Oncol       Date:  2017-05-04

2.  Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver.

Authors:  Timm Kirchhoff; Lars Zender; Sonja Merkesdal; Bernd Frericks; Nisar Malek; Joerg Bleck; Stefan Kubicka; Stefan Baus; Ajay Chavan; Michael-P Manns; Michael Galanski
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.